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ABSTRACT 
Background: While morbidity and mortality following fluid replacement with blood 
products, colloids and crystalloids have been reported, the consequences of these fluids on 
airway and respiratory tissue properties have not been fully characterized. 
Objective: Separate assessment of airway resistance and respiratory tissue mechanics 
following fluid replacement with autologous blood (Group B), colloid (HES 6% 130/0.4, 
Group CO) or crystalloid solution (NaCl 0.9%, Group CR) after haemorrhage. 
Design: Prospective, randomized study. 
Setting: Experimental model of surgical haemorrhage and fluid replacement in rats. 
Participants: Anaesthetized, ventilated rats randomly included in 3 groups (Group B: n=8, 
Group CO: n= 8, Group CR: n=9). 
Intervention: Animals were bled in 6 sequential steps, each manoeuvre targeting a loss of 5% 
of total blood volume. The blood loss was then replaced stepwise in a 1:1 ratio with one of the 
three fluids. 
Main outcome measure: After each step, airway resistance (Raw), tissue damping and 
elastance (H) were determined by forced oscillations. Oedema indices from lung weights and 
histology were also measured. 
Results: Raw decreased in all groups following blood loss (-20.3±9.5[SD]% vs. baseline, 
p<0.05), and remained low following blood replacement (-21.7±14.5% vs. baseline, p<0.05), 
but was normalized by colloid (5.5±10.7%, NS). Crystalloid administration exhibited an 
intermediate reversal effect (-8.4±14.7%, NS). Tissue viscoelasticity increased following both 
blood loss and replacement, with no evidence of a significant difference in H between Groups 
CO and CR (NS). More severe oedema was observed in Groups CR and CO than in Group B 
(p<0.05), with no difference between the colloid and crystalloid solutions. 
Conclusion: This model, which mimics surgical haemorrhage, yields no evidence of a 
difference between colloids and crystalloids with regard to the pulmonary consequences of 
blood volume restoration. The lung functional changes should therefore not play a key role in 
the optimum choice of fluid replacement therapy with these solutions. 
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INTRODUCTION 
 
Blood loss during major surgery is associated with detrimental systemic and pulmonary 
consequences. Fluid replacement strategies under this condition are among the most 
polarizing issues in anaesthesia and intensive care practice. Physicians are routinely 
challenged with the choice of the best fluid replacement strategy for the treatment of 
haemorrhage from among blood products, various types of colloids or crystalloids. As an 
aftermath of the recent meta-analyses concerning the safety of hydroxyethyl-starch (HES) [1], 
this therapy should be considered with great caution, particularly in patients with increased 
capillary leakage. Thus, limited options are available for clinicians in fluid replacement 
strategies, in view of the risk of renal damage associated with the use of HES [2, 3], the 
appreciable costs of albumin, and the defects of haemostasis induced by gelatin solutions [4]. 
Crystalloids remain a rational option, but clinicians are reluctant to choose them because of 
the widespread belief of their fast extravasation, though this belief is based on old studies with 
limited evidence-based results [5-7]. 
We recently demonstrated that acute hypovolaemic shock and subsequent resuscitation with 
autologous blood affects the respiratory mechanics [8]. Although a milder, but sustained 
blood loss during a surgical procedure also requires fluid replacement therapy, the respiratory 
consequences of such a disorder have not been explored. The administration of blood 
products is often regarded as the gold standard therapy in this situation, with the main aim of 
maintaining the oxygen transport capacity. However, no evidence-based data are available 
that would allow a comparison of the changes in lung function between this consensual 
approach and goal-directed fluid therapy with colloids or crystalloids. Therefore the 
experimental study reported here focused on the development of a novel animal model with 
which to mimic continuous, hidden surgical bleeding and replacement of the lost blood. We 
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also set out to compare the effects of blood, colloid and crystalloid solutions on the flow 
resistance of the airways and on the viscoelastic properties of the respiratory tissues and to 
attempt to relate these changes to pulmonary oedema indices. We hypothesized that the 
respiratory consequences of fluid resuscitation with blood differ from those observed after 
colloid and crystalloid solutions.  
 
METHODS 
Ethical approval for this study (no. I-74-50/2012) was provided by the Experimental Ethics 
Committee of the University of Szeged, Szeged, Hungary (Chairperson Prof. Gy. Szabó) on 
7 December 2012, and granted by the Animal Health and Welfare Office of the local 
authorities in Hungary (no. XIV/152/2013, Chairperson Cs. Farle) on 9 January 2013. 
Animal preparations 
Anaesthesia was induced with an intraperitoneal injection of 5% chloral hydrate (400 mg/kg) 
in adult male Sprague Dawley rats (330 ± 38 g). Tracheal intubation was achieved with a 
polyethylene cannula (16-gauge, B. Braun Melsungen AG, Melsungen, Germany) after 
subcutaneous administration of local anaesthetics to ensure adequate analgesia around the 
surgical wound (lidocaine, 2-4 mg/kg). The rats were then placed in a supine position on a 
heating pad and the tracheal cannula was attached to a small animal ventilator (Model 683, 
Harvard Apparatus, South Natick, MA, USA), and mechanically ventilated with room air 
(70 breaths/min, tidal volume 7 ml/kg). A femoral vein was catheterized (Abocath 22 G) for 
drug delivery and for the fluid replacement. A femoral artery was cannulated (Abocath 22 G) 
and attached to a pressure transducer (Model TSD104A, Biopac, Santa Barbara, CA, USA) 
for continuous systemic blood pressure monitoring to assess mean arterial pressure (MAP), 
and to allow blood withdrawal, as part of the experimental protocol. The arterial pressure, 
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ECG and heart rate (HR) were monitored continuously with a data collection and acquisition 
system (Biopac, Santa Barbara, CA, USA). Body temperature was kept in the 37 ± 0.5 C 
range by using the heating pad. 
Measurement of respiratory mechanics 
The forced oscillation technique was applied in short (6-s-long) end-expiratory pauses 
interposed in the mechanical ventilation to measure the input impedance of the respiratory 
system (Zrs), as detailed previously [9]. Briefly, the ventilator was stopped at end-expiration 
and the tracheal cannula was switched from the ventilator to a loudspeaker-in-box system. 
The loudspeaker delivered a computer-generated small-amplitude (<1 cmH2O) pseudorandom 
signal (23 non-integer multiples between 0.5 and 21 Hz) through a 100-cm-long, 2-mm-ID 
polyethylene tube. Two identical pressure transducers (model 33NA002D, ICSensors, 
Milpitas, CA, USA) were used to measure the lateral pressures at the loudspeaker end (P1) 
and at the tracheal end (P2) of the wave-tube. The signals P1 and P2 were low-pass filtered 
(5th-order Butterworth, 25-Hz corner frequency), and sampled with the analogue-digital 
board of a microcomputer at a rate of 256 Hz. Fast Fourier transformation with 4-s time 
windows and 95% overlapping was used to calculate the pressure transfer functions (P1/P2) 
from the 6-s recordings collected during apnoea. Zrs was calculated as the load impedance of 
the wave-tube [10]. The input impedance of the ET tube and the connections was also 
determined, and was subtracted from each Zrs spectrum. 
A model containing a frequency-independent resistance (R) and inertance (I) and a tissue 
damping (G) and elastance (H) of a constant-phase tissue compartment [11] was fitted to the 
Zrs spectra by minimizing the weighted difference between the measured and the modelled 
impedance data. The tissue parameters characterize the damping (resistive) and elastic 
properties of the respiratory system. Raw and Iaw represent primarily the resistance and 
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inertance of the airways, since the contribution of the chest wall to these parameters in rats is 
minor [12].  
Lung histology 
After completion of the experimental protocol, the rats were euthanized with an overdose of 
pentobarbital sodium (300 mg/kg iv). Midline thoracotomy was then performed and 4% 
formaldehyde was instilled into the right lung via the tracheal cannula at a hydrostatic 
pressure of 20 cmH2O after clamping of the left main bronchus near the bifurcation. The right 
lung was dissected and placed into 4% buffered formalin until further processing. After 
complete fixation, transhilar horizontal sections (perpendicular to the longitudinal axes of the 
lung from the hilum) were embedded in paraffin. Two 5-μm sections were prepared in each 
lung specimen and were stained with haematoxylin-eosin. Digitalized images were used to 
obtain the oedema index around randomly selected pulmonary vessels by dividing the lumen 
area by the total area of the pulmonary vessel (oedema cuff area + vessel lumen area). 
Histological images were analysed by the same investigator in a blind fashion and in a 
random sequence by using JMicroVision image analysis software (version 1.2.7).  
Three-to-four tissue samples were dissected from the different lobes of the non-fixated left 
lungs; these samples were weighed to establish the wet-to-dry weight ratio (W/D) as an index 
of the lung water content. 
Experimental protocol 
The rats were randomly assigned into one or other of the three protocol groups. The rats in 
Group B always received autologous heparinized blood (n = 8), while fluid replacement was 
performed with a colloid solution (HES 6% 130/0.4, Fresenius Kabi Deutschland GmbH, Bad 
Homburg v.d.H., Germany) in Group CO (n = 8), or with a crystalloid solution (NaCl 0.9%, 
B. Braun Melsungen AG, Melsungen, Germany) in Group CR (n = 9). The experimental 
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protocol was started with standardization of the lung volume history through the 
administration of a hyperinflation via occlusion of the expiratory port of the ventilator when 
the animal had reached a steady-state condition (5-10 min after the starting of mechanical 
ventilation). The baseline respiratory mechanics was then established by measuring 3 or 4 
reproducible Zrs data epochs. Haemorrhage was next induced by the withdrawal of 5% of the 
estimated total blood volume [13] via the femoral artery (Fig. 1). Three min later, another set 
of Zrs data was collected, including 3 individual measurements at 1-min intervals. The 
withdrawn blood was used for blood gas analyses (Cobas b221; Roche Diagnostics, Basel, 
Switzerland) to determine the haematocrit (Hct), pH and oxygen (PaO2) and carbon dioxide 
(PaCO2) partial tensions. The blood withdrawal and Zrs measurements were repeated once 
again in an identical manner. After completion of the first two steps of arterial haemorrhage, 
fluid replacement in accordance with the group allocations was performed by administering 
5% of the total blood volume via the femoral vein. Three minutes after this manoeuvre, a set 
of Zrs data was recorded. The blood withdrawal-replacement procedure was repeated 4 more 
times, with the collection of Zrs data 3 min after each intervention. The total duration of 
resuscitation was around 90 min with each step lasting approximately 7 min. Further arterial 
blood gas analyses were performed from the fourth and sixth blood samples. After completion 
of the measurement protocol, the lungs were processed for oedema assessment, as detailed 
above. 
Data analysis 
The scatters in the parameters were expressed as SD values. The Kolmogorov-Smirnov test 
was used to test data for normality. Two-way repeated measures of analysis of variances 
(ANOVA) with the factors assessment time and group allocation was used to assess the 
effects of blood loss and replacement on the respiratory mechanical and haemodynamic 
parameters. The baseline respiratory mechanical parameters and oedema indices were 
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compared by using one-way ANOVA tests. The Holm-Sidak multiple comparison procedure 
was applied to compare the different conditions (for repeated measures) or protocol groups 
(for independent groups). Correlation analyses between the variables were performed by 
using Pearson correlation tests. Statistical tests were carried out with the SigmaPlot software 
package (version 12.5, Systat Software, Inc., CA, USA) with a significance level of p < 0.05. 
RESULTS 
The body weights did not exhibit statistically significant differences between the protocol 
groups (344 ± 16.1 g for Group B, 320 ± 51.24 g for Group CO and 361 ± 20.7 g for Group 
CR). Table 1 demonstrates the baseline values of the respiratory mechanical parameters for 
the three experimental groups. No statistically significant differences were detected in the 
variables reflecting the airway or tissue mechanics. 
The arterial blood gas parameters obtained at the beginning, at the midpoint and at the end of 
the experimental protocol are presented in Table 2. In Group B, Hct did not exhibit 
statistically significant changes throughout the protocol, whereas decreases in pH (p < 0.001) 
and PaO2 (p = 0.011) were evidenced. As compared with the autologous blood, fluid 
replacement with colloid solution resulted in a lower Hct (p < 0.001), while crystalloid 
administration led to significant reductions in Hct (p = 0.010) and pH (p = 0.009). No 
difference in the changes in PaO2 and pH was observed between the rats in Groups CR and 
CO. The decreases in Hct were more pronounced in Group CO than those in Group CR 
(p = 0.032). 
Figure 2 depicts the changes in the airway and respiratory tissue mechanical parameters 
relative to the baseline. Blood withdrawal resulted in a systematic lowering of Raw. The fluid 
replacement with colloid in Group CO restored the baseline value of Raw, whereas the Raw 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
9 
 
remained diminished following the iv administration of autologous blood in Group B 
(p = 0.005). The changes in Raw after the iv injections of crystalloid solution in Group CR 
were intermediate (p < 0.038), with less obvious elevations in Raw after the third fluid 
replacement manoeuvre. Monotonous increases in G were observed throughout the protocol 
(p < 0.001), with no statistically detectable differences between the protocol groups. H was 
elevated in all groups, with significantly greater changes in Groups CR (p = 0.005) and CO 
(p = 0.012) than in Group B. 
The oedema parameters obtained from the lung weights and from the histological analyses are 
to be seen in Fig. 3. The animals in both Groups CR and CO exhibited significantly greater 
wet-to-dry lung weight ratios (p < 0.001 for both), as also manifested in the perivascular 
pulmonary oedema indices (p < 0.05 for both). 
The systemic haemodynamic changes for the 3 groups of rats are displayed in Fig. 4. The 
blood withdrawals caused MAP to decrease systematically, while it was restored to the 
previous values by fluid replacements, regardless of the group allocation. HR displayed 
gradual increases in all groups of rats, with significant changes from R3, W3 and R2 in 
Groups B, CR and CO, respectively. 
The relationships between the wet-to-dry lung weight ratio and the relative change in H are 
presented in Fig. 5. Pooling of the data from the 3 protocol groups revealed significant 
correlations between the macroscopic oedema index and the increased stiffness of the 
respiratory system (R = 0.55, p < 0.01).  
 
DISCUSSION 
In the present study, an experimental model that mimics continuous insidious surgical 
bleeding and fluid replacement was applied for a direct assessment of the mechanical 
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properties specific for the airway and respiratory tissues following a blood loss and its 
treatment with solutions commonly used in clinical practice. The decreased airway resistance 
subsequent to the haemorrhage remained low after fluid therapy with autologous blood, 
whereas it has re-elevated back to baseline by the administration of colloid and increased 
partially by fluid replacement with crystalloid. The respiratory tissues stiffened more 
markedly in the animals receiving colloid or crystalloid, with no difference in effect between 
these solutions. These adverse tissue mechanical changes were also reflected in the alterations 
in the oedema indices determined by lung weighing and by histology. 
There has recently been an extensive debate concerning the optimum fluid replacement 
therapy following blood loss from the aspects of the type and the amount of the administered 
solution. While the lungs are primarily affected in consequence of the fluid therapy, no 
information is currently available on the airway and tissue mechanical changes. The 
administration of blood products is often considered to ensure the oxygen transport by 
maintaining the normal haemoglobin content. Restoration of the circulatory blood volume by 
blood products has a beneficial effect on the preservation of sufficient microcirculation with 
minimal morphologic damage or ischaemic cell injury [14, 15]. Similarly to previous 
findings, the blood volume loss in the present study led to bronchodilation, which is most 
probably due to the compensatory increase in thoracic gas volume and/or the elevated levels 
of circulatory catecholamines [8]. The present findings extend these results in a different 
model of haemorrhage without inducing the severe hypovolaemia characteristic of hidden, 
leaking bleeding during major surgery.  
While recent studies have focused on the morbidity and mortality related to colloid or 
crystalloid administrations as fluid replacement therapy [1, 2, 16], the pulmonary effects of 
these solutions are mainly based on empirical investigations without firm evidence [5-7]. As 
far as we are aware, the present study addresses for the first time the respiratory mechanical 
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changes in response to common fluid replacement strategies and attempts to establish their 
relationship to the oedema indices in an experimental model of surgical bleeding. 
Our results demonstrate that the Raw essentially remains lowered after administration of 
autologous blood. The lack of a complete recovery in airway tone may be related to the 
relaxation potential of heparin [17]. However, a comparison of heparinized and non-
heparinized colloid solutions revealed no difference in their bronchial effects (data not 
shown), and the potential role of heparin can therefore be excluded. Alternatively, the 
depressed Raw may be attributed to the presence of bronchoactive mediators in the 
sequestered blood, with the particular importance of the increased levels of adrenaline and 
noradrenaline in the withdrawn and subsequently re-administered blood [8]. Conversely, the 
findings revealed a complete reversal of the haemorrhage-induced bronchodilation by colloid. 
This suggests the importance of the interactions between circulatory changes and airway 
mechanics following a blood loss, with recovery of the original airway geometry through 
restoration by approaching the initial circulatory volume. The increases in Raw following 
colloid administration may be attributed to a distension of the bronchial submucosal vessels 
and/or to the oedema formation resulting in airway wall thickening, or an exudation into the 
airway lumen [18]. A similar concept can be applied to the initial results obtained with 
crystalloid solution, the first administration of which fully reversed the decreased Raw, when 
its entire volume was likely to remain in the vascular bed. This effect of the elevated 
intravascular volume may have been abolished in the rats of Group B due to the presence of 
catecholamines in the readministered autologous blood. 
The tissue viscoelastic parameters following blood administration revealed slight, gradual 
increases, which can be attributed to the atelectasis and subsequent lung volume loss induced 
by the anaesthesia and mechanical ventilation in the supine position. This phenomenon was 
confirmed by the decrease in PaO2, which suggests the loss of alveolar surface available for 
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gas exchange. An important finding of the present study is the more marked gradual 
impairment of the respiratory tissue viscoelasticity in the animals receiving colloid or 
crystalloid solution (Fig. 2). This difference may arise from the variable rheological properties 
of the administered fluids that may contribute to the altered respiratory tissue behaviour [19], 
or from haemodilution-related changes in the colloid osmotic pressures. These phenomena 
result in oedema development affecting directly the tissue viscoelasticity. Since these adverse 
changes were also reflected in the oedema indices (Figs 3 and 5), the primary role of the 
accumulating perivascular oedema fluid in the compromised respiratory tissue stiffness can be 
anticipated. It is noteworthy that no evidence of a difference was found between colloid and 
crystalloid treatments either in the changes in the tissue mechanics or in the oedema indices. 
These results suggest the equivalence of these fluid replacement strategies in terms of 
compromising the lung tissue viscoelasticity, and as regards pulmonary oedema formation. 
This correspondence is also reflected in the lack of difference in the changes of blood 
oxygenation following the two fluid replacement regimes (Table 2). These findings are in 
qualitative agreement with previous results that demonstrated the lack of difference between 
colloid and crystalloid solutions in influencing the extravascular lung water, pulmonary leak 
index and lung injury score [20-22]. However, it should be borne in mind that this may hold 
true only in the relatively short time frame (~90 min) covered by our protocol, and systematic 
assessments of the prolonged effects would require further investigations. 
An important methodological aspect of our protocol is related to the nature and the volume of 
the administered fluid. There is still a debate in the literature on the nature of fluid to be 
considered for resuscitation [23]. Conflicting reports aroused from recent meta-analyses with 
some authors suggesting the safe use of albumin in critically ill patients [24], while others do 
not recommend its use because of lack of robust evidence for its effectiveness to reduce 
mortality [25]. The very recent international consensus promotes the use of crystalloids 
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against both HES and albumin solutions [23]. Since the aim of the present study was 
primarily to compare the effect of three basic fluid replacement strategies, we deliberately 
selected HES, as the colloid solution comparator. As concerns the crystalloid solution, various 
types are available for fluid replacement therapy, with slightly different ingredients resulting 
in somewhat variable osmolarities. Since there is an evolving debate on the choice of 
balanced salt solutions and normal saline, this latter offers similar osmolarity with the other 2 
fluid replacement strategies. Thus, isotonic normal saline rather than the hypotonic Ringer’s 
lactate was selected for a comparison with the slightly hypertonic HES 6% 130/0.4 [26]. As 
concerns the volume of crystalloid solution for fluid replacement, no evidence-based 
recommendations are available. Whereas textbooks conventionally state that the volume of 
crystalloids to be administered should be 3- to 4-fold the blood loss [27], recent studies 
question this, suggesting a ratio close to 1:1 [2, 7, 28]. Since the acute effect of fluid 
replacement was at the focus of interest in the present study, the same volume was chosen for 
the blood loss and replacement for both solutions (5% of the total blood volume). The 
rationale of this approach was confirmed by the lack of difference in MAP and HR between 
the protocol groups, which agrees with the concept of goal-directed therapy [28, 29]. 
A methodological limitation of our findings is associated with the use of total respiratory 
impedance data to assess pulmonary changes. While Raw accurately reflects the flow 
resistance of the airways, the chest wall contributes significantly to the tissue parameters G 
and H [12]. Nevertheless, the viscoelastic properties of the chest wall exhibited negligible 
changes following the induction of severe oedema with oleic acid [30]. Thus, our results are 
likely to reflect pulmonary changes; however, their magnitude may be somewhat 
underestimated due to the masking effect of the chest wall. Another methodological limitation 
is related to the species difference between small rodents and humans necessitating careful 
extrapolation of our data to a clinical situation. While rats have substantially higher Raw, G 
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and H than humans, no major differences exist between mammalian species in the oscillatory 
mechanics besides scaling factor [31].  
In summary, our results have provided experimental evidence of the dissociated changes in 
the airway and tissue mechanical properties following surgical-type bleeding and its treatment 
with autologous whole blood, colloid or crystalloid solution in a volume that fully restored 
mean arterial pressure. The measurement of respiratory mechanical, histological and gas 
exchange consequences of blood loss and consecutive fluid replacement strategies revealed no 
differences between fluid replacement with colloid and crystalloid. The two solutions 
demonstrated similar abilities to compromise the lung tissue viscoelasticity subsequent to 
mild perivascular oedema formation. These findings highlight the differences in behaviour of 
the respiratory system following fluid replacement with blood, colloid or crystalloid: a 
sustained bronchodilation is expected after the administration of autologous blood, without 
significant lung tissue changes, whereas colloids and crystalloids tend to restore the basal 
airway tone at the expense of similar deteriorations in lung tissue viscoelasticity.  
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FIGURE LEGENDS 
Figure 1. Scheme of the experimental protocol. BL: baseline, W1-W6 blood withdrawals, 
R1-R5: fluid replacements, Zrs: measurement of respiratory impedance data, BG: assessment 
of arterial blood gas.  
Figure 2. Changes in the airway (Raw: airway resistance) and tissue mechanics (G: damping, 
H: elastance) relative to the baseline (BL) during blood withdrawals (W1-W6) and fluid 
replacements (R1-R5) with autologous blood (Group B), colloid (Group CO) or crystalloid 
(Group CR). BV: total blood volume. *: p < 0.05 vs. Group B within a condition, #: p < 0.05 
vs. Group CO within a condition. 
Figure 3. Oedema indices obtained by relating the wet lung weight to the dry weight (left) 
and by relating the perivascular oedema area to the total vessel area on histological sections 
obtained in rats receiving autologous blood (Group B), colloid (Group CO) or crystalloid 
(Group CR). *: p < 0.05. 
Figure 4. Systemic haemodynamic parameters (MAP: mean arterial pressure; HR: heart rate) 
during blood withdrawals (W1-W6) and fluid replacements (R1-R5) with autologous blood 
(Group B), colloid (Group CO) or crystalloid (Group CR); BV: total blood volume. 
*: p < 0.05 vs. BL within a group. 
Figure 5. Relationship between the changes in oedema index (wet weight / dry weight) and in 
respiratory elastance (H) in rats receiving autologous blood (Group B), colloid (Group CO) or 
crystalloid (Group CR). 
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Raw 
(cmH2O.s/l) 
G 
(cmH2O/l) 
H 
(cmH2O/l) 
Group B 54.4 (7.6) 1034 (93.2) 5332 (761.6) 
Group CO 52.3 (10.9) 1061 (131.3) 5293 (1139.6) 
Group CR 51.7 (9.9) 912 (105.0) 4533 (546.0) 
Table 1. Mean (SD) values of the airway resistance (Raw), tissue damping (G) and elastance 
(H) obtained under the baseline conditions in the three groups of rats. 
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Hct 
(%) 
pH PaO2
(mmHg) 
W1 W4 W6 W1 W4 W6 W1 W4 W6 
Group B 
34.4 
(3.4) 
34.5 
(5.3) 
33.9 
(2.4) 
7.52 
(0.06) 
7.44* 
(0.06) 
7.43* 
(0.03) 
79.4 
(15.7) 
69.5 
(17.1) 
63.3* 
(14.3) 
Group CO 
32.7 
(3.6) 
31.7 
(3.6) 
24.2
*#
(5.0) 
7.51 
(0.06) 
7.40* 
(0.03) 
7.40
*
(0.06) 
80.4 
(8.7) 
54.9* 
(7.0) 
63.7
*
(6.7) 
Group CR 
33.8 
(2.28) 
31.1 
(7.2) 
28.5
*#$
(5.3) 
7.51 
(0.06) 
7.42* 
(0.03) 
7.36
*#
(0.06) 
79.9 
(16.8) 
63.0* 
(7.8) 
64.9
*
(12.3) 
Table 2. Mean (SD) parameter values derived from arterial blood samples obtained at the first 
(W1), fourth (W4) and last (W6) withdrawal. Hct: haematocrit, PaO2: arterial partial pressure 
of oxygen. *: p < 0.05 vs. W1, #: p < 0.05 vs. Group B, $: p < 0.05 vs. Group CO. 
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